|
Millennium Research Laboratories (MRL), was founded in 2002 by a founding group that possess decades of combined experience in the fields of polymer science, advanced materials, drug discovery, and development. MRL’s facility is located in Woburn, Massachusettes, US. It is designed for formulation work and small scale manufacturing, subdivided into three suites equipped with state-of-the-art instrumentation, and an office space. MRL offers a wide spectrum of services and expertise in scientific, professional, technical, manufacturing, quality control, and regulatory fields. Our services include formulation development, drug delivery design, analytical methods development, validation and drug stability assessment, among other tasks. Contract servicesThe one stop solution to all your analytical problems and more is our contract services:
Bioanalytical services
Stability studiesStability studies (ICH, accelerated, long and short-term as well as photostability)include both standard and custom-order protocols:
Formulation – pre-formulation to optimizationMRLs dosage form understanding of the cost pressures in today’s pharmaceutical environment ensure that we develop products that can be manufactured in a timely and reproducible manner using cost effective materials. Beginning with a concept, the experts at MRL can develop ideas into products. MRL offers the following:
In addition, MRL offers optimization of enhanced solubility, sustained delivery, controlled release, enhanced stability, targeted delivery, improved bioavailability, microencapsulation, acceptability for specialized use, and administration for alternate routes. Extractable and leachable testing design
Millennium Research Laboratories
25 K Olympia Avenue Suite 500 Woburn MA 01801 USA Tel: +1 781 935 0790 Fax: +1 781 935 0791 Email: info@mrl-online.com URL: www.mrl-online.com |
![]() Millennium Research Laboratories (MRL), was founded in 2002 by a founding group that possess decades of combined experience in the fields of polymer science, advanced materials, drug discovery, and development. |